Related Experiment Video
Updated: Dec 18, 2025
10:29
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
8.2K
Is effective patient support missing in the global response to multidrug-resistant tuberculosis?
A M Cocozza1, N N Linh2, E Jaramillo2
1Global Studies Institute, Global Health, University of Geneva, Geneva, Formerly Global Tuberculosis Programme, World Health Organization, Geneva.
Summary
Addressing health systems challenges and implementing patient-centered care are crucial for improving treatment outcomes in multidrug-resistant tuberculosis (MDR-TB). This approach enhances adherence and reduces patient costs, aligning with WHO End TB Strategy goals.
Area of Science:
- Public Health
- Infectious Diseases
- Clinical Medicine
Background:
- Multidrug-resistant tuberculosis (MDR-TB) poses a significant threat to global tuberculosis elimination efforts.
- The World Health Organization (WHO) End TB Strategy highlights the need to address health system challenges for effective MDR-TB treatment.
Purpose of the Study:
- To emphasize the importance of patient-centered care in the clinical and programmatic management of MDR-TB.
- To highlight how addressing health system issues can improve treatment adherence, reduce patient costs, and enhance outcomes.
Main Methods:
- Review of WHO consolidated guidelines for drug-resistant TB treatment.
- Consideration of findings from the STREAM and Delamanid 213 clinical trials.
Main Results:
- Patient-centered approaches are key to improving MDR-TB treatment outcomes.
- Addressing health systems issues supports patient adherence and reduces catastrophic costs.
Conclusions:
- Implementing WHO guidelines for MDR-TB management, with a focus on patient support, is essential for achieving treatment success.
- A comprehensive, patient-centered strategy is vital for combating the global threat of MDR-TB.
Related Concept Videos
01:28Pulmonary Tuberculosis V
460
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
460
01:29Pulmonary Tuberculosis I
733
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
733
01:26Pulmonary Tuberculosis IV
420
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
420
01:29Therapeutic Drug Monitoring: Affecting Factors
118
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
118
01:28Antimicrobial Effectiveness
834
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
834
01:28Pulmonary Tuberculosis II
1.2K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.2K